AI 'nearly twice as accurate' as biopsies at grading some sarcomas
Tests comparing artificial intelligence and standard biopsies revealed that AI had an 86% greater success rate than its competitor, suggests new researc...
Stay updated with breaking news from Bone Sarcoma Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tests comparing artificial intelligence and standard biopsies revealed that AI had an 86% greater success rate than its competitor, suggests new researc...
A recent study conducted by the Royal Marsden NHS Foundation Trust and the Institute of Cancer Research (ICR) highlights AI's capabilities in assessing cancer aggressiveness.
Recent advances in artificial intelligence (AI) are now poised to revolutionize the diagnostic procedures for sarcomas, a rare cancer type.
Researchers have developed an algorithm that predicts how aggressive a tumour is likely to be more accurately than a biopsy.
Researchers in UK say new tool could help ensure patients at high risk are identified promptly